Study identifier:NIS-ORU-XXX-2014/1
ClinicalTrials.gov identifier:NCT02122588
EudraCT identifier:N/A
CTIS identifier:N/A
OVArian cancer Non-Interventional Study. Treatment hAbits and epidemiology of BRCA in Russian Federation - OVATAR
Ovarian, peritoneal, fallopian tube cancer, BRCAm+ in Russia
N/A
No
-
Female
503
Observational
N/A
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verified 01 May 2019 by AstraZeneca
AstraZeneca
RUSSCO (Russian Society of Clinical Oncology)
No locations available
Arms | Assigned Interventions |
---|---|
OVATAR study patients Females with serous and endometrioid ovarian, peritoneal and fallopian tube cancer 18 years and older, diagnosed 3 months before enrolment into the study or later, consented to participate in this non-interventional study, who are being treated for OC, FTC (Fallopian Tube Cancer) and PC (Peritoneal Cancer) in the oncology hospitals/departments in the Russian Federation. | - |